Ledger.Open graph →
SEC Form D · filed June 21, 2023

Veralox Therapeutics Inc

Offering
$25.0M
Sold
$24.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
FREDERICK, MD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Alex Martin · Frederick, MDDirectorKatie Ellias · Frederick, MDDirectorMegan Krench · Frederick, MDDirectorBenjamin Scruggs · Durham, NCDirectorJamie Stiff · Frederick, MDDirectorJonathan Mow · Malvern, PAExec · DirectorMegan Krench · Frederick, MDDirectorAlex Martin · Frederick, MDDirectorBenjamin Scruggs · Durham, NCDirectorJamie Stiff · Frederick, MDDirectorKatie Ellias · Frederick, MDDirectorJonathan Mow · Malvern, PAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗